The global contrast injector systems market was valued at $554.38 million in 2016, and is expected to reach $954.62 million by 2023, registering a CAGR of 8.1% during the forecast period. A contrast injector system is a medical diagnostic device that makes use of a contrast media to create visual representations of the interior of the human body to diagnose, monitor, or treat clinical disorders. The key imaging process includes computed tomography, magnetic resonance imaging, and angiography.... Research Beam Model: Research Beam Product ID: 2736891 5370 USD New
Contrast Injector Systems Market by Product (Injector Systems, Consumables, and Accessories), Application (Interventional Radiology, Interventional Cardiology, and Radiology), and End User (Diagnostics Centers, Clinics, Hospitals, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Contrast Injector Systems Market by Product (Injector Systems, Consumables, and Accessories), Application (Interventional Radiology, Interventional Cardiology, and Radiology), and End User (Diagnostics Centers, Clinics, Hospitals, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
 
 

The global contrast injector systems market was valued at $554.38 million in 2016, and is expected to reach $954.62 million by 2023, registering a CAGR of 8.1% during the forecast period. A contrast injector system is a medical diagnostic device that makes use of a contrast media to create visual representations of the interior of the human body to diagnose, monitor, or treat clinical disorders. The key imaging process includes computed tomography, magnetic resonance imaging, and angiography.

The contrast media enhances the contrast structures or visibility of fluids within the body compared to traditional image processing. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract. Rapid use of medical imaging process through contrast injectors, such as angiography, computed tomography, and magnetic resonance imaging procedures, drives the contrast injector systems market. In addition, increase in geriatric population coupled with high prevalence of chronic diseases worldwide boosts the growth. However, high cost associated with contrast injector systems, and risks related to injector systems and contrast media are expected to impede the market growth. Furthermore, the side effects and allergic reactions associated with the use of contrast media hamper adoption of contrast injector systems in emerging economies. Moreover, the rise in healthcare expenditure and emergence of complex diseases in the developing countries may present lucrative opportunities for key market players.

The global contrast injector systems market is segmented based on product, application, end user, and region. Based on product, it is divided into injector systems, consumables, and accessories. Injector systems are further sub segmented into computed tomography (CT) injector systems, magnetic resonance imaging (MRI) injector systems, and angiography injector systems. The consumables segment is subdivided into injector head, syringes, tubing, and other consumables. Injector head is again divided into single head, dual head, and syringeless injector heads. Based on application, the market is categorized into interventional radiology, interventional cardiology, and radiology. Based on end user, it is classified into diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global contrast injector systems market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

  • Injector Systems
    • CT Injector Systems
    • MRI Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Head
      • Single Head Injectors
      • Dual Head Injectors
      • Syringeless Injectors
    • Syringes
    • Tubing
    • Other Consumables
  • Accessories

By Application

  • Interventional Radiology
  • Interventional Cardiology
  • Radiology

By End User

  • Diagnostics Centers
  • Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Bracco Imaging S.p.A
  • Bayer HealthCare
  • Guerbet Group
  • Medtron AG
  • Ulrich GmbH & Co. KG
  • GE Healthcare
  • Shenzhen Seacrown Electromechanical Co., Ltd
  • Nemoto Kyorindo Co., Ltd
  • Sino Medical- Device Technology Co., Ltd.
  • VIVID IMAGING

The other players in the value chain include (profiles not included in the report)

  • Imaxeon, Pty Ltd
  • Network Imaging Systems
  • IRadimed Corporation
  • Covidien
  • Agito Medical
  • merit medical systems

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. TOP PLAYER POSITIONING, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in number of angiography, CT, and MRI procedures
3.5.1.2. Growth in technological sophistication
3.5.1.3. Rise in geriatric population and increase in chronic diseases

3.5.2. Restraints

3.5.2.1. High cost of contrast injector systems
3.5.2.2. Risk associated with contrast injector systems and contrast media

3.5.3. Opportunities

3.5.3.1. Rise in healthcare expenditure and emergence of complex diseases in developing countries

CHAPTER 4 CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast by product

4.2. INJECTOR SYSTEMS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. CT injector systems

4.2.3.1.1. Market size and forecast

4.2.3.2. MRI injector systems

4.2.3.2.1. Market size and forecast

4.2.3.3. Angiography injector systems

4.2.3.3.1. Market size and forecast

4.3. CONSUMABLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Injector head

4.3.4.1. Market size and forecast
4.3.4.2. Single head injectors

4.3.4.2.1. Market size and forecast

4.3.4.3. Dual head injectors

4.3.4.3.1. Market size and forecast

4.3.4.4. Syringeless injectors

4.3.4.4.1. Market size and forecast

4.3.5. Syringes

4.3.5.1. Market size and forecast

4.3.6. Tubing

4.3.6.1. Market size and forecast

4.3.7. Other consumables

4.3.7.1. Market size and forecast

4.4. ACCESSORIES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast, by application

5.2. INTERVENTIONAL RADIOLOGY

5.2.1. Market size and forecast

5.3. INTERVENTIONAL CARDIOLOGY

5.3.1. Market size and forecast

5.4. RADIOLOGY

5.4.1. Market size and forecast

CHAPTER 6 CONTRAST INJECTOR SYSTEMS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS CENTERS

6.2.1. Market size and forecast

6.3. HOSPITALS

6.3.1. Market size and forecast

6.4. CLINICS

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

CHAPTER 7 CONTRAST INJECTOR SYSTEMS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast, by country
7.2.4. Market Size and forecast, by product
7.2.5. Market size and forecast, by application
7.2.6. Market size and forecast, by end user

7.2.6.1. U.S. market size and forecast, by product
7.2.6.2. U.S. market size and forecast, by application
7.2.6.3. U.S. market size and forecast, by end user
7.2.6.4. Canada market size and forecast, by product
7.2.6.5. Canada market size and forecast, by application
7.2.6.6. Canada market size and forecast, by end user
7.2.6.7. Mexico market size and forecast, by product
7.2.6.8. Mexico market size and forecast, by application
7.2.6.9. Mexico market size and forecast, by end user

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast, by country
7.3.4. Market size and forecast, by product
7.3.5. Market size and forecast, by application
7.3.6. Market size and forecast, by end user

7.3.6.1. Germany market size and forecast, by product
7.3.6.2. Germany market size and forecast, by application
7.3.6.3. Germany market size and forecast, by end user
7.3.6.4. France market size and forecast, by product
7.3.6.5. France market size and forecast, by application
7.3.6.6. France market size and forecast, by end user
7.3.6.7. UK market size and forecast, by product
7.3.6.8. UK market size and forecast, by application
7.3.6.9. UK market size and forecast, by end user
7.3.6.10. Italy market size and forecast, by product
7.3.6.11. Italy market size and forecast, by application
7.3.6.12. Italy market size and forecast, by end user
7.3.6.13. Spain market size and forecast, by product
7.3.6.14. Spain market size and forecast, by application
7.3.6.15. Spain market size and forecast, by end user
7.3.6.16. Rest of Europe market size and forecast, by product
7.3.6.17. Rest of Europe market size and forecast, by application
7.3.6.18. Rest of Europe market size and forecast, by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Asia-Pacific market size and forecast, by country
7.4.4. Asia-Pacific market size and forecast, by product
7.4.5. Asia-Pacific market size and forecast, by application
7.4.6. Asia-Pacific market size and forecast, by end user

7.4.6.1. Japan market size and forecast, by product
7.4.6.2. Japan market size and forecast, by application
7.4.6.3. Japan market size and forecast, by end user
7.4.6.4. China market size and forecast, by product
7.4.6.5. China market size and forecast, by application
7.4.6.6. China market size and forecast, by end user
7.4.6.7. India market size and forecast, by product
7.4.6.8. India market size and forecast, by application
7.4.6.9. India market size and forecast, by end user
7.4.6.10. Australia market size and forecast, by product
7.4.6.11. Australia market size and forecast, by application
7.4.6.12. Australia market size and forecast, by end user
7.4.6.13. Rest of Asia-Pacific market size and forecast, by product
7.4.6.14. Rest of Asia-Pacific market size and forecast, by application
7.4.6.15. Rest of Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. LAMEA market size and forecast, by country
7.5.4. LAMEA market size and forecast, by product
7.5.5. LAMEA market size and forecast, by application
7.5.6. LAMEA market size and forecast, by end user

7.5.6.1. Brazil market size and forecast, by product
7.5.6.2. Brazil market size and forecast, by application
7.5.6.3. Brazil market size and forecast, by end user
7.5.6.4. South Africa market size and forecast, by product
7.5.6.5. South Africa market size and forecast, by application
7.5.6.6. South Africa market size and forecast, by end user
7.5.6.7. Saudi Arabia market size and forecast, by product
7.5.6.8. Saudi Arabia market size and forecast, by application
7.5.6.9. Saudi Arabia market size and forecast, by end user
7.5.6.10. Rest of LAMEA market size and forecast, by product
7.5.6.11. Rest of LAMEA market size and forecast, by application
7.5.6.12. Rest of LAMEA market size and forecast, by end user

CHAPTER 8 COMPANY PROFILE

8.1. BAYER AG

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BRACCO SPA (BRACCO IMAGING SPA)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. GUERBET GROUP

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. MEDTRON AG

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. NEMOTO KYORINDO CO., LTD.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio

8.7. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio

8.9. ULRICH GMBH & CO. KG

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating product categories
8.9.4. Product portfolio

8.10. VIVID IMAGING

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio

LIST OF TABLES

TABLE 1. DIAGNOSTIC PROCEDURES BY COUNTRY
TABLE 2. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 3. CONTRAST INJECTOR SYSTEMS MARKET FOR INJECTOR SYSTEMS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. CONTRAST INJECTOR SYSTEMS MARKET FOR CONSUMABLES, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET FOR INJECTOR HEAD, BY TYPE 2016-2023 ($MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET FOR SYRINGES, BY REGION 2016-2023 ($MILLION)
TABLE 7. GLOBAL CONSUMABLES MARKET FOR TUBING, BY REGION 2016-2023 ($MILLION)
TABLE 8. GLOBAL OTHER CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. CONTRAST INJECTOR SYSTEMS MARKET FOR ACCESSORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 11. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 12. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 13. CONTRAST INJECTOR SYSTEMS MARKET FOR RADIOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 15. CONTRAST INJECTOR SYSTEMS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. CONTRAST INJECTOR SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. CONTRAST INJECTOR SYSTEMS MARKET FOR CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. CONTRAST INJECTOR SYSTEMS MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 19. CONTRAST INJECTOR SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 25. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 26. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. PRODUCTS OFFERED BY BRACCO IMAGING
TABLE 34. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 38. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 42. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 43. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. UK CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 45. UK CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46. UK CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 47. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 48. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 49. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 50. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 51. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 54. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 55. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 56. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 57. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 58. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 59. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 61. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 62. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 63. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 64. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 65. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 66. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 67. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 68. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 69. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 70. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 71. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 75. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 76. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 77. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 78. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 79. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 80. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 81. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 82. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 83. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 84. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 85. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 86. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 87. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 88. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 89. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 90. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 91. BAYER: COMPANY SNAPSHOT
TABLE 92. BAYER: OPERATING SEGMENTS
TABLE 93. BAYER: PRODUCT PORTFOLIO
TABLE 94. BRACCO: COMPANY SNAPSHOT
TABLE 95. BRACCO: OPERATING SEGMENTS
TABLE 96. BRACCO: PRODUCT PORTFOLIO
TABLE 97. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 98. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 99. BRACCO: PRODUCT PORTFOLIO
TABLE 100. GUERBET: COMPANY SNAPSHOT
TABLE 101. GUERBET: OPERATING SEGMENTS
TABLE 102. GUERBET: PRODUCT PORTFOLIO
TABLE 103. MEDTRON : COMPANY SNAPSHOT
TABLE 104. MEDTRON: OPERATING SEGMENTS
TABLE 105. MEDTRON: PRODUCT PORTFOLIO
TABLE 106. NEMOTO: COMPANY SNAPSHOT
TABLE 107. NEMOTO: OPERATING SEGMENTS
TABLE 108. NEMOTO: PRODUCT PORTFOLIO
TABLE 109. SINOMDT: COMPANY SNAPSHOT
TABLE 110. SINOMDT: OPERATING SEGMENTS
TABLE 111. SINOMDT: PRODUCT PORTFOLIO
TABLE 112. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 113. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: OPERATING SEGMENTS
TABLE 114. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 115. ULRICH MEDICAL: COMPANY SNAPSHOT
TABLE 116. ULRICH MEDICAL: PRODUCT CATEGORIES
TABLE 117. ULRICH MEDICAL: PRODUCT PORTFOLIO
TABLE 118. VIVID IMAGING: COMPANY SNAPSHOT
TABLE 119. VIVID IMAGING: OPERATING SEGMENTS
TABLE 120. VIVID IMAGING: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, 2016-2023
FIGURE 3. TOP INVESTMENT POCKETS
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. MODERATE BARGAINING POWER OF BUYERS
FIGURE 7. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 8. HIGH THREAT OF NEW ENTRANTS
FIGURE 9. LOW THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2016
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL CONTRAST INJECTOR SYSTEMS MARKET
FIGURE 13. GLOBAL ELDERLY POPULATION STATISTICS (1990-2100)
FIGURE 14. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT
FIGURE 15. GLOBAL INJECTOR SYSTEMS MARKET FOR CT INJECTOR SYSTEMS, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL INJECTOR SYSTEMS MARKET FOR MRI INJECTOR SYSTEMS, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL INJECTOR SYSTEMS MARKET FOR ANGIOGRAPHY INJECTOR SYSTEMS, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL INJECTOR HEAD MARKET FOR SINGLE HEAD INJECTORS, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL INJECTOR HEAD MARKET FOR DUAL HEAD INJECTORS, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL INJECTOR HEAD MARKET FOR SYRINGELESS HEAD INJECTORS, 2016-2023 ($MILLION)
FIGURE 21. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION
FIGURE 22. SEGMENTATION OF CONTRAST INJECTOR SYSTEMS MARKET, BY END USER
FIGURE 23. SEGMENTATION OF CONTRAST INJECTOR SYSTEMS MARKET, BY REGION
FIGURE 24. BAYER: REVENUE, 2014-2016 ($MILLION)
FIGURE 25. BAYER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 26. BRACCO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 27. BRACCO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 28. GE HEALTHCARE: REVENUE, 2014-2016 ($MILLION)
FIGURE 29. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 30. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 31. GUERBET: NET SALES, 2014-2016 ($MILLION)
FIGURE 32. GUERBET: REVENUE SHARE BY GEOGRAPHY, 2016 (%)